Search Result

Isoforms Recommended:	HDAC5

Results for "

HDAC5

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Apoptosis (3) Autophagy (1) G Protein-coupled Receptor Kinase (GRK) (1) Guanylate Cyclase (1) HDAC (11) NF-κB (1) Small Interfering RNA (siRNA) (3)
By Research Areas:	Cancer (9) Cardiovascular Disease (1) Infection (1) Inflammation/Immunology (1)
Oligonucleotides:	Pre-designed siRNA Sets (3) siRNAs (3)

Inhibitors & Agonists

Peptides

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-112719

BRD 4354 3 Publications Verification	HDAC	Cancer
BRD 4354 is a moderately potent inhibitor of *HDAC5* and *HDAC9, with IC₅₀s* of 0.85 and 1.88 μM, respectively.

HY-18361

TMP195 10+ Cited Publications	HDAC	Cancer
TMP195 is a selective class IIa histone deacetylase (HDAC) inhibitor with K_is of 59, 60, 26, 15 nM for HDAC4, HDAC5, HDAC7 and HDAC9, respectively.

HY-18360

TMP269 10+ Cited Publications	HDAC	Cancer
TMP269 is a novel and selective class IIa histone deacetylase (HDAC) inhibitor with IC₅₀s of 157 nM, 97 nM, 43 nM and 23 nM for HDAC4, HDAC5, HDAC7 and HDAC9, respectively.

HY-18998

LMK-235 Maximum Cited Publications 21 Publications Verification	HDAC	Cancer
LMK-235 is a potent and selective *HDAC4/5* inhibitor, inhibits HDAC5, HDAC4, HDAC6, HDAC1, HDAC2, HDAC11 and HDAC8, with IC₅₀s of 4.22 nM, 11.9 nM, 55.7 nM, 320 nM, 881 nM, 852 nM and 1278 nM, respectively, and is used in cancer research.

HY-12164

Mocetinostat 10+ Cited Publications MGCD0103	HDAC Autophagy Apoptosis	Cancer
Mocetinostat (MGCD0103) is a potent, orally active and isotype-selective HDAC (Class I/IV) inhibitor with IC₅₀s of 0.15, 0.29, 1.66 and 0.59 μM for *HDAC1, HDAC2, HDAC3* and *HDAC11, respectively. Mocetinostat shows no inhibition on HDAC4, HDAC5, HDAC6, HDAC7, or HDAC*8.

HY-RS06076

HDAC5 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
HDAC5 Human Pre-designed siRNA Set A contains three designed siRNAs for HDAC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDAC5 Human Pre-designed siRNA Set A HDAC5 Human Pre-designed siRNA Set A

HY-RS06077

Hdac5 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Hdac5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hdac5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac5 Mouse Pre-designed siRNA Set A Hdac5 Mouse Pre-designed siRNA Set A

HY-RS06078

Hdac5 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Hdac5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Hdac5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac5 Rat Pre-designed siRNA Set A Hdac5 Rat Pre-designed siRNA Set A

HY-112719B

BRD 4354 ditrifluoroacetate	HDAC	Cancer
BRD 4354 (ditrifluoroacetate) is a moderately potent inhibitor of *HDAC5* and *HDAC9, with IC₅₀s* of 0.85 and 1.88 μM, respectively .

HY-P10462

SAP15 Synthetic anti-inflammatory peptide 15	HDAC NF-κB	Inflammation/Immunology
SAP15 (Synthetic anti-inflammatory peptide 15) is a synthetic anti-inflammatory peptide consisting of 15 amino acids designed from human beta-defensin 3. SAP15 has the ability to penetrate cells and is able to induce downregulation of intracellular inflammation. SAP15 inhibits inflammation by inhibiting the phosphorylation of *HDAC5* and thereby reducing the phosphorylation of NF-κB p65. In LPS-induced macrophages, SAP15 inhibits *HDAC5* and NF-κB p65 phosphorylation. In addition, SAP15 treatment increased the expression of aggrecan and type II collagen and decreased the expression of osteocalcin in LPS-induced chondrocytes. SAP15 can be used in the study of inflammation regulation and anti-inflammatory therapy of biomaterials .

HY-152226

MC2590	HDAC Apoptosis	Cancer
MC2590 is a potent pyridine-containing histone deacetylase (HDAC) inhibitor. MC2590 is a inhibitor of HDAC1-3, -6, -8, and -10 (class I/IIb-selective inhibitor) with IC₅₀s of 0.015 μM-0.156 μM. MC2590 also inhibits HDAC isoforms HDAC4, HDAC5, HDAC7, HDAC9, HDAC11 with IC₅₀s of 1.35 μM-3.98 μM. MC2625 induces G2/M cell cycle arrest and modulates pro- and anti-apoptotic microRNAs towards apoptosis induction .

HY-119939

CHDI-390576	HDAC	Cancer
CHDI-390576, a potent, cell permeable and CNS penetrant class IIa histone deacetylase (HDAC) inhibitor with IC₅₀s of 54 nM, 60 nM, 31 nM, 50 nM for class IIa HDAC4, HDAC5, HDAC7, HDAC9, respectively, shows >500-fold selectivity over class I HDACs (1, 2, 3) and ~150-fold selectivity over HDAC8 and the class IIb HDAC6 isoform .

HY-143248

KR-39038	G Protein-coupled Receptor Kinase (GRK) HDAC	Cardiovascular Disease
KR-39038 is an orally active and potent *GRK5* (G protein-coupled receptor kinase 5) inhibitor, with an IC₅₀ of 0.02 μM. KR-39038 significantly inhibits angiotensin II-induced cellular hypertrophy through suppression of *HDAC5* pathway in neonatal cardiomyocytes. KR-39038 shows profound anti-hypertrophic effects and improved cardiac function. KR-39038 can be used for heart failure research .

HY-114548

Ebselen oxide	Guanylate Cyclase	Infection
Ebselen oxide, the selenone analogue of Ebselen, covalently modifies diguanylate cyclase (DGC) to inhibit c-di-GMP-receptor interactions and reduces DGC activity. Ebselen oxide also inhibits alginate production (IC₅₀=14 μM) by Pseudomonas aeruginosa. Ebselen oxide inhibits HDAC1, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, and HDAC9 (IC₅₀ ranging from 0.2 to 4.7 μM) .

HY-152225

MC2625	HDAC Apoptosis	Cancer
MC2625 is a potent pyridine-containing histone deacetylase (HDAC) inhibitor. MC2625 show selective HDAC3 and HDAC6 inhibition with IC₅₀s of 80 nM and 11 nM. MC2625 increases acetyl-H3 and acetyl-tubulin levels and inhibits cancer stem cells (CSCs) growth by apoptosis induction .

Cat. No.	Product Name	Target	Research Area

HY-P10462

SAP15 Synthetic anti-inflammatory peptide 15	HDAC NF-κB	Inflammation/Immunology
SAP15 (Synthetic anti-inflammatory peptide 15) is a synthetic anti-inflammatory peptide consisting of 15 amino acids designed from human beta-defensin 3. SAP15 has the ability to penetrate cells and is able to induce downregulation of intracellular inflammation. SAP15 inhibits inflammation by inhibiting the phosphorylation of *HDAC5* and thereby reducing the phosphorylation of NF-κB p65. In LPS-induced macrophages, SAP15 inhibits *HDAC5* and NF-κB p65 phosphorylation. In addition, SAP15 treatment increased the expression of aggrecan and type II collagen and decreased the expression of osteocalcin in LPS-induced chondrocytes. SAP15 can be used in the study of inflammation regulation and anti-inflammatory therapy of biomaterials .

HDAC5 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
HDAC5 Human Pre-designed siRNA Set A contains three designed siRNAs for HDAC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac5 Mouse Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
Hdac5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hdac5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac5 Rat Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
Hdac5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Hdac5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Name
Email *

	Sorry, but the email address you supplied was invalid.